Teladoc Health Inc
NYSE:TDOC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Teladoc Health Inc
Research & Development
Teladoc Health Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Teladoc Health Inc
NYSE:TDOC
|
Research & Development
-$277.9m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-35%
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Research & Development
-$767.4m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-28%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Research & Development
-$103.2m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Research & Development
-$93m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Research & Development
-$87.7m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-10%
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
Research & Development
-$54.6m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Teladoc Health Inc
Glance View
In the bustling landscape of digital healthcare, Teladoc Health Inc. stands as a pioneering beacon, revolutionizing how medical services are delivered and consumed. Originally founded in 2002 in Dallas, Texas, Teladoc began as a straightforward telemedicine platform offering virtual doctor visits via phone and video calls. Over the years, it has adeptly expanded to provide a comprehensive suite of services, including expert medical opinions, AI-driven health analytics, and management of chronic diseases. Through strategic acquisitions, such as the purchase of Livongo Health, Teladoc broadened its offerings to encompass behavioral health and chronic condition management, thereby creating a holistic ecosystem of care. This integration of services is tailored to meet the diverse health needs of its clients, ranging from individual consumers to large employers and health plans. Teladoc's business model hinges on a subscription-based framework, primarily targeting employers and insurance companies who offer their digital healthcare platform as a valuable benefit to their employees or policyholders. By charging these institutional clients a recurring fee, and also collecting per-visit fees from individuals, Teladoc ensures a steady and reliable revenue stream. With the growing acceptance and demand for telehealth solutions, particularly heightened by global events like the COVID-19 pandemic, Teladoc has seen a significant increase in utilization rates. This surge underscores the company's strategy of continuous innovation and investment in technology that enhances user experience and outcomes, positioning Teladoc as a leader in the future of healthcare delivery.
See Also
What is Teladoc Health Inc's Research & Development?
Research & Development
-277.9m
USD
Based on the financial report for Dec 31, 2025, Teladoc Health Inc's Research & Development amounts to -277.9m USD.
What is Teladoc Health Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-35%
Over the last year, the Research & Development growth was 10%. The average annual Research & Development growth rates for Teladoc Health Inc have been 6% over the past three years , -11% over the past five years , and -35% over the past ten years .